Holen Sie sich die Stockscreener-App
4.95
2.17%
-0.11
Vorhandelsmarkt:
5.25
0.30
+6.06%
Finanzdaten der Monte Rosa Therapeutics Inc-Aktie (GLUE)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
1.064
|
- | - | - | - |
Operating Expenses
|
3.29%
36.01
|
34.86 | 36.97 | 37.22 | 34.26 |
| Benefits Costs and Expenses |
32.95
|
- | - | - | - |
| Costs And Expenses |
32.95
|
- | - | - | - |
| Operating Income/Loss |
0.24%
-34.95
|
-34.86 | -36.97 | -37.22 | -34.26 |
| Nonoperating Income/Loss |
92.70%
3.062
|
1.589 | 2.254 | 2.233 | 2.221 |
| Income/Loss From Continuing Operations Before Tax |
4.17%
-31.89
|
-33.27 | -34.71 | -34.99 | -32.04 |
| Income Tax Expense/Benefit |
477.27%
0.083
|
-0.022 | 0.17 | 0.19 | - |
| Income/Loss From Continuing Operations After Tax |
3.86%
-31.97
|
-33.25 | -34.88 | -35.18 | -32.04 |
|
Net Income/Loss
|
3.86%
-31.97
|
-33.25 | -34.88 | -35.18 | -32.04 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
3,128%
60.16
|
1.8638 | 49.81 | 49.43 | 49.35 |
| Diluted Average Shares |
3,128%
60.16
|
1.8638 | 49.81 | 49.43 | 49.35 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):